Methylthioninium chloride Proveblue Unjoni Ewropea - Malti - EMA (European Medicines Agency)

methylthioninium chloride proveblue

provepharm sas - methylthioninium chloride - metemoglobinemija - il-prodotti terapewtiċi l-oħra kollha - trattament sintomatiku akut ta 'methaemoglobinaemia indotta minn prodotti mediċinali u kimiċi. methylthioninium chloride proveblue huwa indikat fl-adulti, it-tfal u l-adoloxxenti (b'età minn 0 sa 17-il sena).

Lumeblue (previously known as Methylthioninium chloride Cosmo) Unjoni Ewropea - Malti - EMA (European Medicines Agency)

lumeblue (previously known as methylthioninium chloride cosmo)

alfasigma s.p.a. - methylthioninium chloride - colorectal neoplasms; colonoscopy - other diagnostic agents - lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.

Dimethyl fumarate Polpharma Unjoni Ewropea - Malti - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetil fumarate - l-isklerożi multipla, sklerożi multipla li tirkadi u tbatti - immunosoppressanti - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Accord Unjoni Ewropea - Malti - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dimetil fumarate - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosoppressanti - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Mylan Unjoni Ewropea - Malti - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dimetil fumarate - l-isklerożi multipla, sklerożi multipla li tirkadi u tbatti - immunosoppressanti - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Neuraxpharm Unjoni Ewropea - Malti - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dimetil fumarate - l-isklerożi multipla, sklerożi multipla li tirkadi u tbatti - immunosoppressanti - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Teva Unjoni Ewropea - Malti - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - dimetil fumarate - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosoppressanti - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Tecfidera Unjoni Ewropea - Malti - EMA (European Medicines Agency)

tecfidera

biogen netherlands b.v. - dimetil fumarate - sklerosi multipla - immunosoppressanti - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Skilarence Unjoni Ewropea - Malti - EMA (European Medicines Agency)

skilarence

almirall s.a - dimetil fumarate - psorajiżi - immunosoppressanti - skilarence huwa indikat għall-kura tal-moderati għall-plakka severi psoriasis fl-adulti fil-bżonn ta ' terapija mediċinali sistemiċi.

Thorinane Unjoni Ewropea - Malti - EMA (European Medicines Agency)

thorinane

pharmathen s.a. - enoxaparin sodium - tromboemboliżmu tal-vini - aġenti antitrombotiċi - thorinane huwa indikat għall-adulti għall -: - profilassi ta ' tromboemboliżmu fil-vini, partikolarment f'pazjenti li jgħaddu minn kirurġija ortopedika, ġenerali jew onkoloġika-kirurġija. - profilassi ta 'tromboemboliżmu venuż f'pazjenti bedridden minħabba mard akut inkluż akuta insuffiċjenza tal-qalb, waqfien akut tan-nifs, infezzjonijiet gravi, kif ukoll l-aggravament tal-mard rewmatiku li jikkawżaw l-immobbilizzazzjoni tal-pazjent (japplika għall-qawwiet ta' 40 mg/0. 4 ml). - it-trattament ta 'trombożi f' vina fonda (dvt), kkumplikati jew mhux ikkomplikati minn emboliżmu pulmonari. trattament ta 'anġina mhux stabbli u n-non-q-wave' infart mijokardijaku, flimkien ma ' acetylsalicylic acid (asa). - it-trattament ta 'elevazzjoni tas-segment st' infart mijokardijaku (stemi) inklużi pazjenti li ser jiġu ttrattati b'mod konservattiv jew li wara jgħaddu minn koronarju perkutanju l-anġoplastika (japplika għall-qawwiet ta ' 60 mg/0. 6 ml, 80 mg/0. 8 ml, u 100 mg/1 ml). - tagħqid tad-demm għall-prevenzjoni fil-ċ-ċirkolazzjoni ekstrakorporali matul l-emodijalisi. il-prevenzjoni u l-kura ta ' diversi mard relatati mal-emboli tad-demm fl-adulti.